|
1
|
Yang W, Lam P, Kitching R, et al: Breast
cancer metastasis in a human bone NOD/SCID mouse model. Cancer Biol
Ther. 6:1289–1294. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xia TS, Wang GZ, Ding Q, et al: Bone
metastasis in a novel breast cancer mouse model containing human
breast and human bone. Breast Cancer Res Treat. 132:471–486. 2012.
View Article : Google Scholar
|
|
3
|
Fidler IJ: Critical determinants of
metastasis. Semin Cancer Biol. 12:89–96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Z, Schem C, Shi YH, Medina D and Zhang
M: Increased COX2 expression enhances tumor-induced osteoclastic
lesions in breast cancer bone metastasis. Clin Exp Metastasis.
25:389–400. 2008. View Article : Google Scholar
|
|
5
|
Rosol TJ, Tannehill-Gregg SH, Corn S,
Schneider A and McCauley LK: Animal models of bone metastasis.
Cancer Treat Res. 118:47–81. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lynam-Lennon N, Maher SG and Reynolds JV:
The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos
Soc. 84:55–71. 2009. View Article : Google Scholar
|
|
7
|
Qiao J, Lee S, Paul P, et al: miR-335 and
miR-363 regulation of neuroblastoma tumorigenesis and metastasis.
Surgery. 154:226–233. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yi C, Wang Q, Wang L, et al: MiR-663, a
microRNA targeting p21WAF1/CIP1, promotes the
proliferation and tumorigenesis of nasopharyngeal carcinoma.
Oncogene. 31:4421–4433. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pan J, Hu H, Zhou Z, et al:
Tumor-suppressive miR-663 gene induces mitotic catastrophe growth
arrest in human gastric cancer cells. Oncol Rep. 24:105–112.
2010.PubMed/NCBI
|
|
10
|
Yau WL, Lam CS, Ng L, et al:
Over-expression of miR-106b promotes cell migration and metastasis
in hepatocellular carcinoma by activating epithelial-mesenchymal
transition process. PLoS One. 8:e578822013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dynoodt P, Speeckaert R, De Wever O, et
al: miR-145 overexpression suppresses the migration and invasion of
metastatic melanoma cells. Int J Oncol. 42:1443–1451.
2013.PubMed/NCBI
|
|
12
|
Li LZ, Zhang CZ, Liu LL, et al: miR-720
inhibits tumor invasion and migration in breast cancer by targeting
TWIST1. Carcinogenesis. 35:469–478. 2014. View Article : Google Scholar
|
|
13
|
Wang C, Bian Z, Wei D and Zhang JG:
miR-29b regulates migration of human breast cancer cells. Mol Cell
Biochem. 352:197–207. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kutner RH, Zhang XY and Reiser J:
Production, concentration and titration of pseudotyped HIV-1-based
lentiviral vectors. Nat Protoc. 4:495–505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yin JJ, Selander K, Chirgwin JM, et al:
TGF-beta signaling blockade inhibits PTHrP secretion by breast
cancer cells and bone metastases development. J Clin Invest.
103:197–206. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kang Y, Siegel PM, Shu W, et al: A
multigenic program mediating breast cancer metastasis to bone.
Cancer Cell. 3:537–549. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen C, Ridzon DA, Broomer AJ, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Li M, Zang W, et al: MiR-429
up-regulation induces apoptosis and suppresses invasion by
targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol
(Dordr). 36:385–394. 2013. View Article : Google Scholar
|
|
20
|
Sun Y, Shen S, Liu X, et al: miR-429
inhibits cells growth and invasion and regulates EMT-related marker
genes by targeting Onecut2 in colorectal carcinoma. Mol Cell
Biochem. 390:19–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smith RA, Brooks D, Cokkinides V, Saslow D
and Brawley OW: Cancer screening in the United States, 2013: a
review of current American Cancer Society guidelines, current
issues in cancer screening, and new guidance on cervical cancer
screening and lung cancer screening. CA Cancer J Clin. 63:88–105.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weigelt B, Peterse JL and van’t Veer LJ:
Breast cancer metastasis: markers and models. Nat Rev Cancer.
5:591–602. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mundy GR: Metastasis to bone: causes,
consequences and therapeutic opportunities. Nat Rev Cancer.
2:584–593. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weilbaecher KN, Guise TA and McCauley LK:
Cancer to bone: a fatal attraction. Nat Rev Cancer. 11:411–425.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi Y, Chen C, Zhang X, et al:
Primate-specific miR-663 functions as a tumor suppressor by
targeting PIK3CD and predicts the prognosis of human glioblastoma.
Clin Cancer Res. 20:1803–1813. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiao L, Deng Z, Xu C, et al: miR-663
induces castration-resistant prostate cancer transformation and
predicts clinical recurrence. J Cell Physiol. 229:834–844. 2014.
View Article : Google Scholar
|
|
28
|
Wang J, Tian X, Han R, et al:
Downregulation of miR-486-5p contributes to tumor progression and
metastasis by targeting protumorigenic ARHGAP5 in lung cancer.
Oncogene. 33:1181–1189. 2014. View Article : Google Scholar :
|
|
29
|
Korpal M and Kang Y: The emerging role of
miR-200 family of microRNAs in epithelial-mesenchymal transition
and cancer metastasis. RNA Biol. 5:115–119. 2008. View Article : Google Scholar
|
|
30
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen J, Wang L, Matyunina LV, Hill CG and
McDonald JF: Overexpression of miR-429 induces
mesenchymal-to-epithelial transition (MET) in metastatic ovarian
cancer cells. Gynecol Oncol. 121:200–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pasquinelli AE: MicroRNAs and their
targets: recognition, regulation and an emerging reciprocal
relationship. Nat Rev Genet. 13:271–282. 2012.PubMed/NCBI
|
|
33
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: an alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ten HJ, Kaartinen V, Fioretos T, et al:
Cellular interactions of CRKL, and SH2-SH3 adaptor protein. Cancer
Res. 54:2563–2567. 1994.
|
|
35
|
Heaney C, Kolibaba K, Bhat A, et al:
Direct binding of CRKL to BCR-ABL is not required for BCR-ABL
transformation. Blood. 89:297–306. 1997.PubMed/NCBI
|
|
36
|
Senechal K, Halpern J and Sawyers CL: The
CRKL adaptor protein transforms fibroblasts and functions in
transformation by the BCR-ABL oncogene. J Biol Chem.
271:23255–23261. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Uemura N, Salgia R, Ewaniuk DS, Little MT
and Griffin JD: Involvement of the adapter protein CRKL in
integrin-mediated adhesion. Oncogene. 18:3343–3353. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Uemura N and Griffin JD: The adapter
protein Crkl links Cbl to C3G after integrin ligation and enhances
cell migration. J Biol Chem. 274:37525–37532. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Graf R, Barbero S, Keller N, et al:
Src-inducible association of CrkL with procaspase-8 promotes cell
migration. Cell Adh Migr. 7:362–369. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li L, Guris DL, Okura M and Imamoto A:
Translocation of CrkL to focal adhesions mediates integrin-induced
migration downstream of Src family kinases. Mol Cell Biol.
23:2883–2892. 2003. View Article : Google Scholar : PubMed/NCBI
|
